US Biomax, Inc.

ST961

Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores

Microarray Panel:Gastric adenocarcinoma tissue microarray, containing 25 cases of stomach adenocarcinoma, 4 stomach mucinous adenocarcinoma, 3 stomach signet-ring cell carcinoma, 2 stomach undifferentiated carcinoma, 1 each of stomach carcinoid and B cell lymphoma, 3 stomach interstitialoma, plus 6 gastritis and 3 normal stomach tissue, duplicate cores per case
Cores:96
Cases:48
Layout:12 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.

Notes:1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most of the TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). We still recommend 30 minutes of baking at 60°C before putting into xylene for de-paraffinization procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789101112 
A Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
B Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
C Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
D Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
E Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
F Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
G Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
H Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Marked point
Legend: Sto - Stomach

- Benign tumor, - Inflammation, - Malignant tumor, - Malignant tumor, - Malignant tumor (stage II), - Malignant tumor (stage IIIa), - Malignant tumor (stage IV), - Malignant tumor (stage Ib), - Metaplastic, - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 59 Stomach Adenocarcinoma 1 II T3N0M0 Malignant
A2 2 M 64 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
A3 3 F 50 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
A4 4 M 73 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
A5 5 M 82 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
A6 6 M 38 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
A7 7 F 72 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
A8 8 M 58 Stomach Adenocarcinoma 2 II T2N1M0 Malignant
A9 9 F 55 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
A10 10 M 66 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
A11 11 M 69 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
A12 12 M 56 Stomach Adenocarcinoma 2 IIIa T3N1M0 Malignant
B1 13 M 59 Stomach Adenocarcinoma 1 II T3N0M0 Malignant
B2 14 M 64 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
B3 15 F 50 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
B4 16 M 73 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
B5 17 M 82 Stomach Adenocarcinoma 2–3 Ib T2N0M0 Malignant
B6 18 M 38 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
B7 19 F 72 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
B8 20 M 58 Stomach Adenocarcinoma 2 II T2N1M0 Malignant
B9 21 F 55 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
B10 22 M 66 Stomach Adenocarcinoma 2–3 Ib T2N0M0 Malignant
B11 23 M 69 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
B12 24 M 56 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
C1 25 M 58 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
C2 26 M 35 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
C3 27 M 40 Stomach Adenocarcinoma 3 IIIa T4N0M0 Malignant
C4 28 M 65 Stomach Adenocarcinoma 3 IIIa T4N0M0 Malignant
C5 29 M 70 Stomach Adenocarcinoma (sparse) 3 Ib T2N0M0 Malignant
C6 30 M 74 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
C7 31 M 56 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
C8 32 F 45 Stomach Adenocarcinoma 3 IV T4N0M1 Malignant
C9 33 M 48 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
C10 34 M 75 Stomach Adenocarcinoma 4 Ib T2N0M0 Malignant
C11 35 M 35 Stomach Adenocarcinoma 4 Ib T2N0M0 Malignant
C12 36 M 64 Stomach Adenocarcinoma 3 II T2N1M0 Malignant
D1 37 M 58 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
D2 38 M 35 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
D3 39 M 40 Stomach Adenocarcinoma 3 IIIa T4N0M0 Malignant
D4 40 M 65 Stomach Adenocarcinoma 3 IIIa T4N0M0 Malignant
D5 41 M 70 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
D6 42 M 74 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
D7 43 M 56 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
D8 44 F 45 Stomach Adenocarcinoma 3 IV T4N0M1 Malignant
D9 45 M 48 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
D10 46 M 75 Stomach Adenocarcinoma 4 Ib T2N0M0 Malignant
D11 47 M 35 Stomach Adenocarcinoma 4 Ib T2N0M0 Malignant
D12 48 M 64 Stomach Adenocarcinoma 3 II T2N1M0 Malignant
E1 49 M 62 Stomach Adenocarcinoma (lymph node tissue and fibrous tissue) Ib T2N0M0 Malignant
E2 50 F 52 Stomach Mucinous adenocarcinoma 1 II T3N0M0 Malignant
E3 51 F 60 Stomach Mucinous adenocarcinoma 1 Ib T2N0M0 Malignant
E4 52 M 58 Stomach Signet-ring cell carcinoma Ib T2N0M0 Malignant
E5 53 F 48 Stomach Signet-ring cell carcinoma Ib T2N0M0 Malignant
E6 54 M 51 Stomach Mucinous adenocarcinoma 3 II T3N0M0 Malignant
E7 55 M 48 Stomach Mucinous adenocarcinoma 3 Ib T2N0M0 Malignant
E8 56 F 51 Stomach Signet-ring cell carcinoma Ib T2N0M0 Malignant
E9 57 M 58 Stomach Undifferentiated carcinoma Ib T2N0M0 Malignant
E10 58 M 69 Stomach Undifferentiated carcinoma Ib T2N0M0 Malignant
E11 59 F 64 Stomach Carcinoid Ib T2N0M0 Malignant
E12 60 M 47 Stomach Diffuse B cell lymphoma Malignant
F1 61 M 62 Stomach Adenocarcinoma (sparse) Ib T2N0M0 Malignant
F2 62 F 52 Stomach Mucinous adenocarcinoma 1 II T3N0M0 Malignant
F3 63 F 60 Stomach Mucinous adenocarcinoma 1 Ib T2N0M0 Malignant
F4 64 M 58 Stomach Signet-ring cell carcinoma Ib T2N0M0 Malignant
F5 65 F 48 Stomach Signet-ring cell carcinoma Ib T2N0M0 Malignant
F6 66 M 51 Stomach Mucinous adenocarcinoma 3 II T3N0M0 Malignant
F7 67 M 48 Stomach Mucinous adenocarcinoma 3 Ib T2N0M0 Malignant
F8 68 F 51 Stomach Signet-ring cell carcinoma Ib T2N0M0 Malignant
F9 69 M 58 Stomach Undifferentiated carcinoma Ib T2N0M0 Malignant
F10 70 M 69 Stomach Undifferentiated carcinoma Ib T2N0M0 Malignant
F11 71 F 64 Stomach Carcinoid Ib T2N0M0 Malignant
F12 72 M 47 Stomach Diffuse B cell lymphoma Malignant
G1 73 F 67 Stomach Interstitialoma Benign
G2 74 M 64 Stomach Interstitialoma Benign
G3 75 M 63 Stomach Interstitialoma Benign
G4 76 M 27 Stomach Chronic gastritis (smooth muscle) Inflammation
G5 77 M 41 Stomach Chronic atrophic gastritis with intestinal metaplasia Metaplastic
G6 78 F 53 Stomach Chronic atrophic gastritis with intestinal metaplasia Metaplastic
G7 79 M 70 Stomach Chronic gastritis Inflammation
G8 80 M 39 Stomach Chronic superficial gastritis Inflammation
G9 81 M 62 Stomach Chronic superficial gastritis Inflammation
G10 82 M 35 Stomach Normal stomach tissue Normal
G11 83 M 48 Stomach Normal stomach tissue Normal
G12 84 M 50 Stomach Normal stomach tissue Normal
H1 85 F 67 Stomach Interstitialoma Benign
H2 86 M 64 Stomach Interstitialoma Benign
H3 87 M 63 Stomach Interstitialoma Benign
H4 88 M 27 Stomach Chronic gastritis Inflammation
H5 89 M 41 Stomach Chronic atrophic gastritis with intestinal metaplasia Metaplastic
H6 90 F 53 Stomach Chronic atrophic gastritis with intestinal metaplasia Metaplastic
H7 91 M 70 Stomach Chronic gastritis Inflammation
H8 92 M 39 Stomach Chronic superficial gastritis Inflammation
H9 93 M 62 Stomach Chronic superficial gastritis Inflammation
H10 94 M 35 Stomach Normal stomach tissue Normal
H11 95 M 48 Stomach Normal stomach tissue Normal
H12 96 M 50 Stomach Normal stomach tissue Normal
M 58 Skin Malignant melanoma (tissue marker) Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis


Find overlapping cases with this tissue array: